During the past decade, Hospital de Caridade de Ijui conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 20 clinical trials were completed, i.e. on average, 64.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 12 clinical trials were completed. i.e. 92.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Caridade de Ijui" #1 sponsor was "Pfizer" with 8 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Caridade de Ijui" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "Actoverco" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Caridade de Ijui" are "Non-small Cell Lung Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Metastatic Breast Cancer" (3 trials), "Breast Cancer" (2 trials) and "Cervical Cancer" (2 trials). Many other conditions were trialed in "Hospital de Caridade de Ijui" in a lesser frequency.

Most popular intervention types in "Hospital de Caridade de Ijui" are "Drug" (43 trials), "Biological" (9 trials), "Diagnostic Test" (1 trials), "Dietary Supplement" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (7 trials), "Carboplatin" (6 trials), "Paclitaxel" (6 trials), "Placebo" (6 trials) and "Pembrolizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Caridade de Ijui" are 29 trials for "All" genders, 9 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Caridade de Ijui". undefined are not yet recruiting, 7 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Hospital de Caridade de Ijui, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Caridade de Ijui, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Hospital de Caridade de Ijui has several departments that took part in Clinical trials: "Hospital de Caridade de Ijui; Oncologia" - 16 trials